XML 36 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segments
 6 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Business Segments Business Segments
Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC 280. Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses.

The tables below summarize information about our reportable segments.
 Three Months Ended September 30, 2020
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$216,575 $20,847 $237,422 
Cost of sales91,069 8,692 99,761 
Gross profit125,506 12,155 137,661 
Advertising and marketing34,014 4,327 38,341 
Contribution margin$91,492 $7,828 99,320 
Other operating expenses 26,417 
Operating income $72,903 
* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.

 Six Months Ended September 30, 2020
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$427,233 $39,583 $466,816 
Cost of sales178,896 16,391 195,287 
Gross profit248,337 23,192 271,529 
Advertising and marketing58,694 7,397 66,091 
Contribution margin$189,643 $15,795 205,438 
Other operating expenses 52,416 
Operating income $153,022 
* Intersegment revenues of $1.6 million were eliminated from the North American OTC Healthcare segment.


 Three Months Ended September 30, 2019
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$213,878 $24,191 $238,069 
Cost of sales92,931 8,387 101,318 
Gross profit 120,947 15,804 136,751 
Advertising and marketing34,595 4,072 38,667 
Contribution margin$86,352 $11,732 98,084 
Other operating expenses 28,736 
Operating income $69,348 
* Intersegment revenues of $0.8 million were eliminated from the North American OTC Healthcare segment.
 Six Months Ended September 30, 2019
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$424,662 $45,561 $470,223 
Cost of sales181,742 17,663 199,405 
Gross profit 242,920 27,898 270,818 
Advertising and marketing65,609 7,859 73,468 
Contribution margin$177,311 $20,039 197,350 
Other operating expenses 56,516 
Operating income $140,834 
* Intersegment revenues of $1.6 million were eliminated from the North American OTC Healthcare segment.

The tables below summarize information about our segment revenues from similar product groups.
Three Months Ended September 30, 2020
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$30,623 $267 $30,890 
Cough & Cold14,796 3,086 17,882 
Women's Health61,492 4,106 65,598 
Gastrointestinal31,718 6,379 38,097 
Eye & Ear Care26,767 3,037 29,804 
Dermatologicals27,875 836 28,711 
Oral Care21,944 3,134 25,078 
Other OTC1,360 2 1,362 
Total segment revenues$216,575 $20,847 $237,422 

Six Months Ended September 30, 2020
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$58,490 $541 $59,031 
Cough & Cold28,234 6,988 35,222 
Women's Health126,902 6,537 133,439 
Gastrointestinal61,768 12,084 73,852 
Eye & Ear Care49,619 5,582 55,201 
Dermatologicals55,495 1,535 57,030 
Oral Care44,110 6,313 50,423 
Other OTC2,615 3 2,618 
Total segment revenues$427,233 $39,583 $466,816 
Three Months Ended September 30, 2019
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$28,831 $243 $29,074 
Cough & Cold20,506 5,814 26,320 
Women's Health59,678 2,905 62,583 
Gastrointestinal32,214 9,028 41,242 
Eye & Ear Care22,286 3,185 25,471 
Dermatologicals28,039 576 28,615 
Oral Care21,063 2,439 23,502 
Other OTC1,261 1 1,262 
Total segment revenues$213,878 $24,191 $238,069 

Six Months Ended September 30, 2019
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$57,366 $473 $57,839 
Cough & Cold37,846 11,196 49,042 
Women's Health119,256 5,324 124,580 
Gastrointestinal63,786 16,013 79,799 
Eye & Ear Care49,039 6,196 55,235 
Dermatologicals53,777 1,266 55,043 
Oral Care41,042 5,091 46,133 
Other OTC2,550 2 2,552 
Total segment revenues$424,662 $45,561 $470,223 

Our total segment revenues by geographic area are as follows:
Three Months Ended September 30, Six Months Ended September 30,
2020201920202019
United States$203,289 199,714$402,635 $400,343 
Rest of world34,133 38,355 64,181 69,880 
Total$237,422 $238,069 $466,816 $470,223 

Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows:
September 30, 2020North American OTC
Healthcare		International OTC
Healthcare		Consolidated
(In thousands)
Goodwill$546,643 $31,276 $577,919 
Intangible assets 
Indefinite-lived2,195,617 81,066 2,276,683 
Finite-lived, net200,033 4,520 204,553 
Intangible assets, net2,395,650 85,586 2,481,236 
Total$2,942,293 $116,862 $3,059,155 
March 31, 2020North American OTC
Healthcare		International OTC
Healthcare		Consolidated
(In thousands)
Goodwill$546,643 $28,536 $575,179 
Intangible assets 
Indefinite-lived2,195,617 69,714 2,265,331 
Finite-lived, net209,604 4,456 214,060 
Intangible assets, net2,405,221 74,170 2,479,391 
Total$2,951,864 $102,706 $3,054,570